News

Clinical Study Seeks Participants with Lung Disease

Published Date:

Idiopathic pulmonary fibrosis (IPF) is a type of lung disease that results in scarring (fibrosis) of the lungs for an unknown reason. Over time, the scarring gets worse and it becomes harder to take deep breaths. The lungs become unable to take in enough oxygen.

Dr. Rajagopal Sreedhar is recruiting participants for a clinical trial to see if pulmonary rehabilitation treatments improve the quality of life for patients with IPF. The study will compare standard of care treatment to exercise and education. The goal is test how well the combination of exercise and medication benefits the patient. All study-related visits and tests will be provided at no cost to the participant. Participants may also receive a stipend to cover travel and other related expenses.

To qualify, participants must:

  • Be 40 years of age or older
  • Have been diagnosed with IPF
  • Be currently taking the medication Ofev® (150 mg twice a day) and have taken it at a stable dose for up to 30 months

To learn more about this study, contact Abigail House, RN, at 217-545-7526.

More from SIU News

Ashley-Ann Walker

Ashley-Ann Walker named a 2024 SIU Distinguished Student

The SIU System Board of Trustees and its Student Advisory Committee recently honored some outstanding students from across its campuses with the 2024 SIU System Distinguished Student Service Award.
Morgan Suhre at luncheon

Medical school community displays creativity in 2024 Scope

SIU School of Medicine unveiled the 2024 edition of SCOPE at an awards reception April 12. The student-produced literary magazine contains short stories, poems and artwork from learners, faculty, staff, alumni and friends of the school.
therapist

Mental health first aid training

Empowering individuals to be a part of the solution Recently the Behavioral Health Workforce Center (BHWC) began offering Mental Health First Aid training to employees as part of its mission to bring